| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $6.1B | $5.7B | $5.3B | $4.9B | $2.9B | $1.6B | $5.5B | $5.5B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $0.9B | $0.9B | $0.8B | $0.8B | $-0.3B | $-1.0B | $0.8B | $0.5B |
| Net Income | $0.8B | $0.7B | $0.7B | $0.6B | $-0.0B | $-0.7B | $0.9B | $1.1B |
| EPS (Basic) | $1.11 | $0.99 | $1.04 | $0.89 | $-0.02 | $-1.04 | $1.26 | $1.47 |
| EPS (Diluted) | $1.10 | $0.99 | $1.04 | $0.88 | $-0.02 | $-1.04 | $1.26 | $1.47 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $13.0B | $13.0B | $12.2B | $12.3B | $12.4B | $12.9B | $12.3B | $12.1B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $0.8B | $0.6B | $1.1B | $0.7B | $0.8B | $2.3B | $1.6B | $1.5B |
| Total Liabilities | $6.3B | $6.3B | $5.4B | $5.4B | $5.8B | $6.5B | $4.8B | $4.4B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $6.6B | $6.6B | $6.6B | $6.7B | $6.4B | $6.3B | $7.3B | $7.5B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.5B | $1.5B | $1.4B | $1.4B | $0.3B | $-0.3B | $1.3B | $1.3B |
| Investing Cash Flow | $-0.5B | $-2.0B | $-0.2B | $-0.6B | $-1.2B | $-0.2B | $0.1B | $0.1B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $-0.9B | $-0.0B | $-0.8B | $-0.9B | $-0.7B | $1.2B | $-1.3B | $-0.7B |